Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2019 Publisher: Actavis Group PTC ehf, Reykjavikurvegur 76-78, 220 Hafnarfjordur, Iceland
Lansoprazole 15 mg Gastro-Resistant Capsules.
| Pharmaceutical Form |
|---|
|
Lansoprazole 15 mg: opaque yellow cap and body capsules. Each capsule contains white or almost white spherical microgranules. |
Each capsule contains 15 mg lansoprazole.
Excipient with known effect: Each 15 mg capsule contains 100.474 mg sucrose.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Lansoprazole |
Lansoprazole is a gastric proton pump inhibitor. It inhibits the final stage of gastric acid formation by inhibiting the activity of H+/K+ ATPase of the parietal cells in the stomach. The inhibition is dose-dependent and reversible, and the effect applies to both basal and stimulated secretion of gastric acid. |
| List of Excipients |
|---|
|
Sugar spheres (sucrose and maize starch) Capsule shell: Gelatin |
Al/Al blister.
Pack sizes: 7, 14, 28, 56 and 98 capsules.
Not all pack sizes may be marketed.
Actavis Group PTC ehf, Reykjavikurvegur 76-78, 220 Hafnarfjordur, Iceland
PL 30306/0148
08/10/2008
Renewal Approved: 26/06/2013
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
